Pralatrexate
Active substance: pralatrexate
INJECTION · PRALATREXATE 40 mg/2mL
United StatesActive
Marketing holder: Dr.Reddy's Laboratories Inc.,
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- PRALATREXATE · 40 mg/2mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-be1c-7d86-bef7-d630432f1770,01a1208e-af88-7593-9907-40568c8715d7,01a1208f-afe2-780d-9649-a5523a76848a,01a1208f-afe5-7cf5-a5b2-55526984f64d,01a12099-1a5d-7f40-b653-0817aed1a564;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 43598-343
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 43598-343 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 43598-343 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 43598-343 · Verified 2026-10-09 · open in source